With the launch of Johnson & Johnson Vision’s photochromic contact lens, the first to adapt to changing light conditions, the future of contact lens technology is looking bright. We take a look at how the field has developed in recent years and where the next breakthroughs may lie.
Also, we speak to Dr Loubna Bouarfa, CEO and founder of Cambridge-based healthcare AI company OKRA Technologies, to find out more about how environmental and health data can help pharmaceutical companies determine when and where to deploy their medications, round up the state of medical device regulation around the world, and examine the fallout from illegally marketed devices to see what can be done to stop them harming patients.
Plus, we take a look at the ways that manufacturers can demonstrate eco-conscious design principles in a product’s design, development and production, and explore the state of play for the medical devices used for blood management and transfusion.
And, as always, we round up the latest news from the medical device industry, and get comment and analysis from GlobalData’s healthcare analysts.
In this issue
Eye on the prize: how contact lens technology is changing
With the launch of Johnson & Johnson Vision’s photochromic contact lens, the first to adapt to changing light conditions, Abi Millar looks at the growing field of contact lens technology, how it has developed over the years, and where the next breakthroughs may lie.
Okra technologies: accessible AI for smarter healthcare
Okra technologies has developed an artificial intelligence platform which can use environmental and health data to tell pharmaceutical companies where and when to deploy their medications. Chloe Kent caught up with company founder and chief executive Dr Loubna Bouarfa to find out more.
The implant files: their impact on global device regulation
Governments around the world are calling for stricter regulations on medical devices following an international probe into improperly designed implements. But, how are different countries approaching this issue? Chloe Kent rounds up the state of medical device regulation worldwide.
A wolf in sheep’s clothing: clamping down on unauthorised medical devices
Recently, the FDA released a statement cautioning consumers against using unapproved apps and devices for diagnosing concussions. But, how are manufacturers getting away with illegally marketing devices and what can be done to stop them harming patients? Abi Millar finds out.
Making sustainable medical devices: five top tips
The need for sustainable manufacturing practices is more pressing than ever and medical devices are no exception. Chloe Kent caught up with thought leaders from across the industry to pull together five top tips for manufacturers.
Cell salvage: the tech at the cutting edge of blood management
In April 2019, Illinois-based Ecomed Solutions launched HEMAsavR, a blood management device that can be installed in operating theatres to collect a patient’s lost blood during surgery and return it to their body. Known as cell salvage, this technology could have a huge impact on the way surgeries are carried out, bypassing the cost and risk associated with allogeneic blood transfusion. Chloe Kent reports.
Next issue preview
In the next issue of Medical Technology, we examine the rise of ablation technology in the treatment of solid tumours, profile prominent features in the German medical device market, and find out how technology can improve adult vaccination rates.
Also, we take a look at AorTech’s move into medical device manufacturing, review a new light emitting device that could take photodynamic therapy to the next level, and explore the budding promise of 3D biopsies.
Plus, we examine two very different research strands that are working to boost the prevention of deadly cardiac disease and check in with CMR’s Versius robotic surgery tech.